Back

Reducing recurrence, enhancing success: the role of substrate modification in atrial fibrillation redo procedures

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Diving into atrial fibrillation ablation Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marta Vilela

Hospital De Santa Maria, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Re-accessibility and the long-term safety after suture-mediated vascular closure systems usage for femoral vein access
Doctor A. Chikata (Toyama, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of far-field capture in a box-scar lesion: a two-dimensional analysis
Doctor R. Kato (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Efficacy of vein of Marshall ethanol infusion for recurrent persistent atrial fibrillation in patients with durably isolated pulmonary veins
Doctor Y. Kitami (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation (PFA) Marshall plan including Marshall vein ethanol infusion approach in primary intent for persistent atrial fibrillation treatment.
Professor A. Da Costa (Saint-Etienne, FR)
Abstract Slides Video
Presentation thumbnail
Endocardial unipolar voltage mapping of left atrial posterior wall after surgical epicardial radiofrequency ablation to accurately determine transmural scar.
Doctor T. Shigeta (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Diving into atrial fibrillation ablation

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Substrate based ablation
thumbnail
Congress Presentation
Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study
thumbnail
Congress Presentation
Dynamic left atrial substrate in patients undergoing redo ablation for atrial fibrillation recurrence

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources